Royalty Report: Drugs, Therapeutic, Disease – Collection: 3175

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Therapeutic
  • Disease
  • Biotechnology
  • Pharmaceuticals

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 3175

License Grant
The Licensee has entered into a license agreement with the Licensor, to obtain an exclusive license to certain RNAi sequences to a number of target genes for the development of rxRNA® compounds.
Field of Use
The Field of Use focuses on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNAi-targeted technologies.

IPSCIO Record ID: 28685

License Grant
The Licensee entered into a License Agreement with the Licensor.

The Licensee obtained an exclusive License to certain RNAi sequences to a number of target genes for the development of the Licensee's rxRNA compounds.

The Licensee has obtained the right to License additional RNAi sequences, under the same terms, disclosed by the Licensor in its pending patent applications against target genes and has received an option for exclusivity for other siRNA configurations.

Field of Use
The Field of Use apply to the medical industry relating to genes.

IPSCIO Record ID: 28033

License Grant
The Licensee and a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs with disease modifiers, entered into an Agreement with the Licensor regarding financial assistance to be provided for the development of one or more oral therapeutic products for the treatment of Alzheimer's Disease.
Field of Use
The Field of Use relates to the medical industry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.